Australie - anglais - Department of Health (Therapeutic Goods Administration)

merz australia pty ltd - incobotulinumtoxina, quantity: 50 u - injection, powder for - excipient ingredients: albumin; sucrose - xeomin is indicated in adults for the treatment of:,? cervical dystonia (spasmodic torticollis),? blepharospasm,? spasticity of the upper limb,? chronic sialorrhea due to neurological disorders,? upper facial lines,- glabellar frown lines,- lateral periorbital lines (crow?s feet),- horizontal forehead lines,xeomin is indicated in children and adolescents aged 2 years to 17 years for the symptomatic treatment of:,? chronic sialorrhea due to neurological/neurodevelopmental disorders,? spasticity of the lower and/or upper limbs

Israël - anglais - Ministry of Health

medison pharma ltd - botulinum toxin type a - powder for solution for injection - botulinum toxin type a 300 u/vial - botulinum toxin - dysport is indicated for symptomatic treatment of focal spasticity of:- upper limbs in adults due to stroke or traumatic brain injury- lower limbs in adults affecting the ankle joint due to stroke or traumatic brain injury (tbi) - dynamic equinus foot deformity in ambulant paediatric cerebral palsy patients, two years of age or older.- upper limbs in pediatric cerebral palsy patients, two years of age or older.dysport is indicated in adults for symptomatic treatment of:- spasmodic torticollis- blepharospasm- hemifacial spasm.dysport is indicated for symptomatic treatment of persistent severe primary hyperhidrosis of the axillae, which interferes with the activities of daily living and is resistant to topical treatment.dysport is indicated for the temporary improvement in the appearance of moderate to severe:- glabellar lines (vertical lines between the eyebrows) seen at frown,and/or - lateral canthal lines (crow’s feet lines) seen at maximum smile in adult patients under 65 years, when the severity of these lines has an important psychological impact on the patient.

Israël - anglais - Ministry of Health

medison pharma ltd - botulinum toxin type a - powder for solution for injection - botulinum toxin type a 500 u/vial - botulinum toxin - dysport is indicated for symptomatic treatment of focal spasticity of:- upper limbs in adults due to stroke or traumatic brain injury- lower limbs in adults affecting the ankle joint due to stroke or traumatic brain injury (tbi) - dynamic equinus foot deformity in ambulant paediatric cerebral palsy patients, two years of age or older.- upper limbs in pediatric cerebral palsy patients, two years of age or older.dysport is indicated in adults for symptomatic treatment of:- spasmodic torticollis- blepharospasm- hemifacial spasm.dysport is indicated for symptomatic treatment of persistent severe primary hyperhidrosis of the axillae, which interferes with the activities of daily living and is resistant to topical treatment.dysport is indicated for the temporary improvement in the appearance of moderate to severe:- glabellar lines (vertical lines between the eyebrows) seen at frown,and/or - lateral canthal lines (crow’s feet lines) seen at maximum smile in adult patients under 65 years, when the severity of these lines has an important psychological impact on the patient.

Singapour - anglais - HSA (Health Sciences Authority)

ipsen pharma singapore pte. ltd. - clostridium botulinum type a toxin-haemagglutinin complex - injection, powder, for solution - clostridium botulinum type a toxin-haemagglutinin complex 300u/vial

Israël - anglais - Ministry of Health

rafa laboratories ltd - naloxone hydrochloride (as dihydrate); oxycodone hydrochloride - tablets prolonged release - naloxone hydrochloride (as dihydrate) 15 mg; oxycodone hydrochloride 30 mg - oxycodone and naloxone - targin is indicated for the relief of moderate to severe pain.the oxycodone component is indicated for the relief of moderate to severe pain in adults who require continuous around the- clock opioid analgesia for several days or more. the opioid antagonist naloxone is added to counteract opioid-induced constipation by blocking the action of oxycodone at opioid receptors locally in the gut.

Australie - anglais - APVMA (Australian Pesticides and Veterinary Medicines Authority)

imtrade australia pty ltd - glyphosate present as the isopropylamine salt - aqueous concentrate - glyphosate present as the isopropylamine salt glycine active 450.0 g/l - herbicide - agricultural area - general | annual grass weed - seed set control | avocado | banana | blueberry | calomba daisy seed set contr - african lovegrass | amaranth or amaranthus | amsinckia | annual or wimmera ryegrass | annual phalaris | annual ryegrass | annual ryegrass - suppression | artichoke thistle | australian bluebell - w. stricta | bamboo (bambusa spp.) | barbed wire grass | barley grass | barnyard grass or water grass | bent grass - agrostis capillaris | bent grass - agrostis tenuis | bitou bush or boneseed | black speargrass | blackberry | bladder ketmia | blady grass | boggabri weed | boxthorn | bracken | brome grass | brome grass - bromus unioloides | burr medic | californian thistle | calomba daisy | caltrop - tribulis terrestis | caltrop or yellow vine | canary grass | canary grasses | capeweed | carpet grass | cat's ear or flatweed | chickweed | chinese scrub | cobbler's pegs | cocksfoot | couch | crofton weed | cudweed | dock | dock - seedling | english couch or rope twitch | erodium, crowfoot or storksbill | fumitory | grain sorghum - pre harvest | ground cherry - physalis angulata | ground or annual ground cherry | ground

Australie - anglais - Department of Health (Therapeutic Goods Administration)

ferring pharmaceuticals pty ltd - terlipressin, quantity: 0.85 mg - injection, solution - excipient ingredients: sodium chloride; water for injections; sodium acetate trihydrate; acetic acid - glypressin is indicated for the:,?treatment of bleeding oesophageal varices (bov);,?treatment of patients with type 1 hepatorenal syndrome (hrs) who are actively beingconsidered for liver transplant.

Australie - anglais - Department of Health (Therapeutic Goods Administration)

interpharma pty ltd - terlipressin, quantity: 1.7 mg - injection, solution - excipient ingredients: sodium chloride; glacial acetic acid; sodium hydroxide; hydrochloric acid; water for injections - terlipressin ever pharma solution for injection is indicated for the: - treatment of bleeding oesophageal varices; - treatment of patients with hepatorenal syndrome (hrs) type 1 who are actively being considered for liver transplant.

Australie - anglais - Department of Health (Therapeutic Goods Administration)

interpharma pty ltd - terlipressin, quantity: 0.85 mg - injection, solution - excipient ingredients: sodium chloride; glacial acetic acid; sodium hydroxide; hydrochloric acid; water for injections - terlipressin ever pharma solution for injection is indicated for the: - treatment of bleeding oesophageal varices; - treatment of patients with hepatorenal syndrome (hrs) type 1 who are actively being considered for liver transplant.

Australie - anglais - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - felodipine, quantity: 10 mg - tablet, modified release - excipient ingredients: magnesium stearate; hypromellose; colloidal anhydrous silica; lactose monohydrate; titanium dioxide; purified talc; povidone; propyl gallate; iron oxide yellow; propylene glycol; iron oxide red; microcrystalline cellulose - hypertension.